It's going to be a new diagnostic kit for the Covid-19, faster, more precise and economical than the one currently used in all the laboratories of the world, developed in Israel and produced in Rome. The idea is to market a kit home to be able to perform the examination without clogging up the medical facilities, probably intended primarily for the Us market, where in these days many of the citizens have done the test, you are seen to deliver the accounts by more than $ 1,000. To announce the new kit, this week should receive the mark of the european medical device CE, is an official statement, the israeli company BATM Advanced Communications Ltd) Hod Hasharon, quoted on the stock markets of London and Tel Aviv. The production, which started in Rome, The company states that “the group has started the production of the kit in its structure Adaltis in Rome” and that it is “working with academic institutions and research, primarily in Europe, to develop the kit and offer it at a price appropriate for the large-scale production” following “all the recommendations of the Centers for Disease Control and Prevention”. Zvi Marom, founder in 1992 of the group of biotechnology which today has about 1,000 workers, including engineers and scientists, and is currently the CEO of the company in an interview with the Jerusalem Post explained the details of the new kit that has a very low cost of only 1 NIS (about 26 euro cents) per test, amounting to a quarter of current cost buffer around the euro. More important, the cost is the insurance of the near-elimination of false positives and the increased speed of the result. “We received news about the virus from our chinese colleagues receiving from them the sequence of the virus,” said Marom, “and we understood that it was a cousin of SARS, and diseases MERS”. So, he continues, “we took what we had in our research on SARS and MERS, and we added to them the COVID-19 and we have developed a new kit just for these three diseases that can be used with hospital equipment existing”. A kit home is The biomedical division of the BATM part in the advantage because for years he decided to specialize on diagnostics of infectious diseases, a sector often considered the second floor by the Big Pharma, said Marom, who instead believes that “viruses, bacteria, fungi are still the killer more fatal on the face of the earth”. For the Ceo of the israeli society, for the COVID-19 “the diagnosis will be an important issue, not because this is a very dangerous virus, but because it spreads very quickly”. And for this he proposed that his company would also have the opportunity to put soon on the market a kit home to do in home testing for the new Coronavirus, at least as a first screening without clogging up the health care facilities already in emergency. On this possibility, however, there is still nothing official, but only internal discussions in the course. Meanwhile, the announcement of the kit, the shares of the israeli company have jumped more than 20% on the London Stock Exchange.
"The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence"
Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today to Find alternative solutions to the lessons suspended due to a virus, The minister Jay: “No you are political. A plan for the maturity” of The tangling of power The paradox of Milan: from the city-the miracle on the sick imaginary to Live with the fragility